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Abstract
Background: Premature labor is a poorly understood condition. Estrogen is thought to play a key
role and therefore the labor process may be affected by endocrine disruptors. We sought to
determine whether or not an environmental toxicant, DDE, or dietary derived endocrine
disruptors, daidzein and genistein, are associated with spontaneous preterm labor.
Methods: Cases were defined as primiparous patients having a preterm delivery at or before 35
weeks following the spontaneous onset of labor. Controls were defined as primiparous women
who delivered on the same day as the cases but at term gestation.
Over approximately 1 year, 26 cases and 52 controls were recruited. Subjects agreed to have blood
tests on day one postpartum for DDE and for the phytoestrogens genistein and daidzein.
Results: The mean concentration of DDE was similar in the case and control groups: 4.29 vs 4.32
ng/g lipid p = .85. In the case group, 13/26 had detectable levels of daidzein (range 0.20 – 1.56 ng/
ml) compared to 25/52 controls (range 0.21 – 3.26 ng/ml). The mean concentration of daidzein was
similar in cases compared to controls: 0.30 vs .34 ng/ml p = 0.91. Of the case group,14/26 had
detectable levels of genistein (range 0.20 – 2.19 ng/ml) compared to 32/52 controls (range 0.21 –
2.55 ng/ml). The mean concentration of genistein was similar in cases compared to controls: 0.39
vs 0.31 ng/ml, p = 0.61.
Conclusion: The serum levels of DDE in this population were found to be low.
There appears to be no relationship between serum concentrations of DDE, daidzein, and genistein 
and spontaneous preterm labor in our population. The inability to identify an effect may be related 
to the comparatively low concentrations of DDE in our population and the rapid and variable 
reduction of phytoestrogens from women in labor.
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Background
Premature delivery occurs after spontaneous labor in
approximately 6% of pregnancies (<37 weeks gestation)
and remains the single, most important, cause of perinatal
mortality and morbidity [1,2]. The pathophysiology of
preterm labor is not entirely clear but reproductive hor-
mones, such as progesterone and estrogen appear to have
a role. Progesterone is widely regarded as promoting uter-
ine quiescence. Estrogen, on the other hand, may promote
myometrial activation with increased receptivity to utero-
tonic agents by up regulating membrane receptors and
gap junctions[3]. Therefore, endocrine disruptors, espe-
cially those that have estrogen like effects, may have a role
in preterm labor.
The phytoestrogens are of increasing interest owing to
their estrogenic properties and ubiquitous exposure from
a variety of foods and the ability of individuals to alter the
exposure through soy supplementation [4]. These chemi-
cals have been shown to exert estrogenicity through bind-
ing to the ErB receptor. With regard to pregnancy,
genistein and daidzein have been isolated in amniotic
fluid with evidence of transfer from the mother to the
fetus [5,6]. Phytoestrogens have also been associated with
regulation of the HOX genes that are particularly of inter-
est in pregnancy [7,8] and have been shown to reduce the
release of HCG from human placentas at term in vitro [9].
Furthermore, the oral administration of phytoestrogens
have been reported to reverse the anti-estrogenic actions
of clomiphene citrate on the endometrial lining [10].
DDT and PCBs have also been of interest in the pathogen-
esis of premature labor and have shown to increase myo-
metrial contractility in-vitro [11-13]. A large,
retrospective, U.S., cohort study reported an association
between maternal serum DDE, the metabolite of DDT,
and premature delivery [14]. However, the serum samples
were from women delivering in the 1960's when DDT use
was much more prevalent. A subsequent small, case con-
trol study of patients in New York found no relationship
between serum DDE levels and premature delivery [15].
The phytoestrogens, genistein and daidzein, are also of
interest. These chemicals have inherent estrogenic activity
on the Erα and Erβ receptors and have been isolated in
human amniotic fluid [16]. Previous work at our center
had documented significant levels of the DDT metabolite
DDE in maternal serum in a cross sectional survey [17]. In
addition, in this cross sectional survey, a significant
number of women were also found to have detectable lev-
els of the phytoestrogens daidzein and genistein in both
serum samples and in amniotic fluid [18]. Furthermore,
there was a strong correlation of serum and amniotic fluid
concentrations within subject, suggesting that for these
chemicals, a serum sample provides a reliable monitor of
internal, fetal exposure to these estrogenic compounds.
Our population also has a very high rate of premature
delivery with 10% of births in 2004 occurring before 37
weeks gestation (unpublished local data). Therefore, we
sought to evaluate two types of endocrine disruptors, a
environmental contaminant that has previously been
associated with preterm labor, DDE, and two common
dietary derived phytoestrogens, daidzein and genistein.
The study was approved by our local Ethics Review Board.
Methods
Cases were defined as primiparous women having a pre-
mature delivery at greater than 23 weeks and less than 35
weeks gestation following spontaneous labor. The gesta-
tional age of <35 weeks was chosen as this corresponds to
clinically significant premature labor and this definition
has been used in many contemporary studies in prematu-
rity [19-23]. Cases were approached on day one postpar-
tum for consent by the study nurse and asked for a serum
sample. After recruiting a case, the next 10 women who
delivered a term infant, and were within 5 years of age of
the case subject, were approached until two controls were
recruited. Only primigravid subjects were included in the
study in order to avoid the confounding problems that
occur in organochlorine exposure from the substantial
reduction in total body burden through previous parturi-
tion and breast feeding[24,25]. Women with a stillbirth or
a fetus with known congenital anomalies were not
included. Based on our preliminary data, we intended to
recruit 26 cases and 52 control subjects. DDE was
extracted from serum by solid phase extraction. Lipids
were then removed from the extract and DDE was ana-
lyzed by gas chromatography/mass spectrometry (GC/
MS). The limit of quantification for DDE was 0.05 ng/ml.
Lipid concentrations were determined gravimetrically.
Phytoestrogen (daidzein and genistein) conjugates in
serum were hydrolyzed by enzymes in helix Pomatia. The
compounds were then extracted from the sample with lip-
ids removed. The phytoestrogens were derivatized via tri-
methylsilylation and analyzed by GC/MS. The limit of
quantification for daidzein and genistein was 0.20 ng/ml.
Undetectable levels were assigned a value of .001 ng/ml
for analysis. We had deuterated internal standards for
daidzein and genistein and internal standards for DDE in
which the recovery was close to 100%. The sample size
was based on a cross sectional survey of women in the sec-
ond trimester of pregnancy[18]. In that study, the mean
serum concentration of daidzein was 4.75 ng/ml, with a
standard error of 3.52 (range 0–136.2 ng/ml). Based on
these estimates, 12 cases and 24 controls were estimated
to be required to have 80% power to detect a 50% differ-
ence in the mean serum daidzein levels between the two
groups. The analysis was planned in advance. It was antic-
ipated that the levels of DDE and of the phytoestrogens
would be skewed and that transformation of the data
would be required. Univariate analysis was planned usingEnvironmental Health 2007, 6:35 http://www.ehjournal.net/content/6/1/35
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the student's t-test. Multivariate logistic regression was
planned using potential confounders, such as weight and
smoking during pregnancy.
Results
The demographic characteristics of the subjects were sim-
ilar and are provided in Table 1. During recruitment only
3 eligible cases declined to participate. The women in the
study were born between 1964 and 1983 and were
recruited in 2002. DDE levels were corrected for serum
lipid concentration. The median corrected DDE level in
cases was 67.02 ng/g lipid, range (28.57, 431.88) and in
controls was 69.29 ng/g lipid, range (15.79, 618.52). Fig-
ure 1. As the DDE levels were positively skewed, they were
log transformed for further analysis. The log mean con-
centration of DDE was similar in the case and the control
groups: 4.29 vs 4.32 ng/g lipid p = .85 (see Table 2).
Adjusted analysis by multivariate logistic regression with
variables for maternal weight, smoking and log DDE also
failed to demonstrate an association with premature
delivery OR = 1.15 (.47, 2.78).
In the case group, 13/26 had detectable levels of daidzein
(range 0.20 – 1.56 ng/ml) compared to 25/52 controls
(range 0.21 – 3.26 ng/ml). Figure 2. For genistein, 14/26
of the case group had detectable levels (range 0.20 – 2.19
ng/ml) compared to 32/52 controls (range 0.21 – 2.55
ng/ml). Figure 3. As this data was also negatively skewed,
log transformation was performed, prior to any further
analysis. The mean concentration of daidzein was similar
in cases and controls: 0.30 vs .34 ng/ml p = 0.91. The
mean concentration of genistein was similar in cases and
controls: 0.39 vs 0.31 ng/ml, p = 0.61. Adjusted analysis
was performed with multivariate logistic regression with
variables for log genistein or diadzein levels, maternal
weight, and smoking. In this analysis, neither daidzein
nor genistein levels was associated with premature deliv-
ery: OR = .96 (.81, 1.14), OR = .92 (.77, 1.10) respectively.
Addition of both daidzein and genistein together in the
model, again, did not suggest any additive or interactive
effects, OR = 1.03(.81,1.31), OR = .90(.70,1.15) respec-
tively. Further analysis, including terms for both DDE and
daidzein or genistein levels in the same model, again did
not show any evidence of additive or interaction effects
(data not shown).
Discussion
Our study did not demonstrate an association between
spontaneous premature labor and serum DDE levels. Our
results, considered with the results of another case control
study on a contemporary population[15], would suggest
that DDE exposure is not currently a risk factor for prema-
turity. One obvious explanation for our results is that, as
DDE is no longer in widespread use in North America.
Therefore, our subjects are not exposed to the same levels
of this toxicant as women delivering in the 1960's who
had been the subject of previous studies [14]. In our
study, the median DDE concentrations were lower: 0.43
ng/ml range 0.16, 2.98 in cases compared to controls 0.49
ng/ml range 0.09, 3.34. It is also possible that our study
was not large enough to detect small differences between
the case and control group. Still, a post-hoc power calcu-
lation suggests that we had 100% power to detect a 50%
increase in DDE levels in cases compared to controls. Our
results were also similar to those of the other contempo-
rary case control study[15] in which the median DDE lev-
els were 1.3 ng/ml range 0.5, 17.9 in cases and 1.35 range
ng/ml 0.6, 4.0 in controls. However, the levels we
observed were substantially lower than those reported by
Longnecker et. al., where the majority of normal and pre-
term birth subjects had concentrations well above 15 ug/
l[14]. We, also, reported significantly lower levels of DDE
than the Child Health and Development study, in which,
the median levels of all subjects was 7 ug/l range 43,
153[26]. Therefore, our results cannot be generalized to
regions where subjects can be anticipated as having higher
levels of DDE. Furthermore, our study, unlike Longnecker
et al[14], included only women with spontaneous prema-
ture delivery rather than all premature births of which one
third follow induced labor. Indeed, Longnecker's study,
also, identified that having a small for gestational age
(SGA) fetus was associated with DDE levels, even with the
preterm cases removed. It is equally possible that had they
excluded induced labor, for which preterm SGA is a com-
mon indication, that the association with prematurity
would no longer have been evident. Furthermore, our
study is the only one we know of that has restricted enroll-
ment to primiparous subjects. As prematurity is associated
with primiparity and previous pregnancy and breastfeed-
ing decreases the total body DDE load [26-28] this could
Table 1: Maternal characteristics and pregnancy outcome.
Cases (n = 26) Controls (n = 52)
Age 29.2 (19–35) 29.7 (22–38)
Maternal weight (kg) 75.4 (55–130) 77.5 (54–165)
Gestational age at delivery (weeks) 30.5 (24–35) 39.8 (37–42)
Birth weight (gm) 1580 (670–2518) 3817 (2606–4612)
Smoker %(n) 12 (3) 4 (2)Environmental Health 2007, 6:35 http://www.ehjournal.net/content/6/1/35
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have been an unrecognized confounder in previous stud-
ies.
Although our previous work had suggested that the pla-
centa and uterus are being exposed to significant levels of
the phytoestrogens daidzein and genistein, their levels
were not associated with spontaneous premature delivery.
One limitation is that we were not able to measure a
cumulative exposure to the phytoestrogens and that we
had to rely on a single post-partum serum level. It would
be difficult and expensive to have performed serial meas-
urements and, as it is difficult to predict the onset of pre-
mature labor, even a prospective study would have similar
limitations. Genistein and diadzein levels appear to peak
approximately 6 hours after intake and their half lives are
approximately 6 and 8 hours respectively[29]. Inevitably,
the subject's levels will vary depending on their peak level
and time from their last ingestion of phytoestrogens. This
variability could certainly impair our ability to document
any association between premature labor and serum lev-
els. However, it would have been difficult to standardize
collection relative to the last phytoestrogen intake. We
choose instead to accept this variability and instead recruit
patients as soon after delivery as possible. We suspect that
even given this variability if phytoestrogens were strongly
associated with premature labor we would see indications
of this association even with serum samples taken hours
after the last intake. However, future investigations should
take these factors into consideration with study design.
Like any observational study confounding bias is always a
possible explanation for the observed results. We control-
led for the two strongest potential confounding factors:
primiparity and previous preterm delivery by restriction.
Maternal age was controlled for by matching. We also
adjusted for other confounders such as maternal weight
and smoking in the analysis. We did not however have
information on socioeconomic status, a modestly strong
risk factor and there is always the possibility that
unknown confounders could have affected our results.
As with any negative study, a possible explanation for our
results is inadequate power. While we accept this poten-
tial criticism, we point out that not only were the differ-
ences we observed not statistically significant but that our
point estimates were also very close to the null value.
However, it is still possible that the effect of these phytoes-
trogens may be mediated by complex interactions with
other estrogenic compounds, as has been indicated in
studies using the rat uterotrophic assay [30]. As our study
was only able to examine the possible additive effects of
DDE and genistein and daidzein we cannot rule out the
Post partum serum Diadzein levels (ng/ml) in Cases (n = 26)  vs Controls (n = 52) Figure 2
Post partum serum Diadzein levels (ng/ml) in Cases (n = 26) 
vs Controls (n = 52).
Table 2: Serum DDE cases vs controls.
Cases (n = 26) Controls (n = 52) P value
DDE (median, range) .43 ng/ml (.16, 2.98) .49 ng/ml (.09, 3.34)
DDE corrected for lipid (median, range) 67.02 ng/g lipid (28.57, 431.88) 69.29 ng/g lipid (15.79, 618.52)
Log DDE (mean, SD) 4.29 ng/g lipid (.62) 4.33 ng/g lipid (.66) .85
Post partum serum DDE levels (ng/ml) in Cases (n = 26) vs  Controls (n = 52) Figure 1
Post partum serum DDE levels (ng/ml) in Cases (n = 26) vs 
Controls (n = 52).Environmental Health 2007, 6:35 http://www.ehjournal.net/content/6/1/35
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possible interactions with other agents. This may be a sub-
ject for further investigation.
Conclusion
In this case control study, maternal serum levels of DDE,
and the phytoestrogens, daidzein and genistein were not
associated with spontaneous premature delivery. There is
still a possibility that higher exposure to these substances
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